- Home
- TYL vs BNTX Comparison
TYL vs BNTX Comparison
Compare TYL & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYL
- BNTX
- Stock Information
- Founded
- TYL 1966
- BNTX 2008
- Country
- TYL United States
- BNTX Germany
- Employees
- TYL N/A
- BNTX N/A
- Industry
- TYL Computer Software: Prepackaged Software
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TYL Technology
- BNTX Health Care
- Exchange
- TYL Nasdaq
- BNTX Nasdaq
- Market Cap
- TYL 25.0B
- BNTX 26.4B
- IPO Year
- TYL N/A
- BNTX 2019
- Fundamental
- Price
- TYL $562.84
- BNTX $111.00
- Analyst Decision
- TYL Buy
- BNTX Strong Buy
- Analyst Count
- TYL 12
- BNTX 18
- Target Price
- TYL $680.50
- BNTX $141.60
- AVG Volume (30 Days)
- TYL 304.6K
- BNTX 731.1K
- Earning Date
- TYL 07-23-2025
- BNTX 08-04-2025
- Dividend Yield
- TYL N/A
- BNTX N/A
- EPS Growth
- TYL 50.34
- BNTX N/A
- EPS
- TYL 6.63
- BNTX N/A
- Revenue
- TYL $2,190,609,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- TYL $10.16
- BNTX N/A
- Revenue Next Year
- TYL $9.72
- BNTX $10.68
- P/E Ratio
- TYL $83.25
- BNTX N/A
- Revenue Growth
- TYL 9.96
- BNTX 0.61
- 52 Week Low
- TYL $509.19
- BNTX $76.53
- 52 Week High
- TYL $661.31
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- TYL 42.95
- BNTX 58.01
- Support Level
- TYL $550.00
- BNTX $105.35
- Resistance Level
- TYL $595.21
- BNTX $114.00
- Average True Range (ATR)
- TYL 12.36
- BNTX 2.50
- MACD
- TYL -3.67
- BNTX 0.36
- Stochastic Oscillator
- TYL 28.40
- BNTX 73.75
About TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.